Search

everythinglearnresearchcommunity

for

Search:↓

5-alpha-reductase inhibitors may help stabilize or slow down hair loss in some frontal fibrosing alopecia patients, but more research is needed to confirm their effectiveness and safety.

A three-month treatment with a GnRH agonist significantly lowered androgen levels and 5α-reductase activity in men with benign prostatic hyperplasia.

AR-27 E-Chol siRNA can effectively regrow hair by reducing androgen receptor gene activity.

Dermatologists recommend oral dutasteride for male hair loss, low-dose oral minoxidil for female hair loss, and a multidisciplinary approach for young patients, with caution during pregnancy.

In 2007, prostate cancer research improved understanding of risk, diagnosis, and treatment, but also showed heart risks with certain therapies and the need for personalized care.

Baricitinib effectively improved both atopic dermatitis and alopecia areata symptoms in a patient.

Baricitinib was effective in treating both early and late onset alopecia areata.

Finasteride and dutasteride may increase the risk of suicide and sexual dysfunction.

A cholesterol-free liposomal platform using protopanaxadiol effectively promotes hair growth and treats alopecia.

The compounds tested could potentially treat hair loss and alopecia.

Minoxidil can reduce functions related to androgen receptors.

Baricitinib is a relatively safe and effective treatment for severe alopecia areata.

SARM-induced changes in the androgen receptor are specific to each ligand and affect stability and protein interactions.

Saw palmetto may improve urinary symptoms with fewer sexual side effects compared to some medications.

The document concluded that various dermatological treatments have different effectiveness and side effects, with some causing irritation, allergic reactions, or systemic effects.

Oral tofacitinib effectively treats alopecia areata long-term with manageable side effects.

Ritlecitinib may be more effective for severe alopecia areata than conventional treatments.

Oral isotretinoin and cyproterone compound are equally effective for treating acne in women with cutaneous hyperandrogenism.

Biochanin A from soy is a promising and safe candidate for treating hair loss.

Baricitinib effectively reduces hair loss in severe alopecia areata and is generally safe.

Finasteride and dutasteride reduce unwanted movements from Parkinson's disease treatment by normalizing certain brain signals.

BPH medications may increase the risk of self-harm and depression, especially in the first 18 months.

New Finasteride conjugate improves prostate treatment and vital signs in rats.

Five-alpha reductase inhibitors, like finasteride and dutasteride, can treat enlarged prostates, improve urination, reduce need for prostate surgery, and lower the risk of prostate cancer, but may increase the risk of higher grade prostate cancer. They can also treat male pattern baldness.

Finasteride and dutasteride can cause severe, lasting side effects.

The 0.05% dutasteride topical solution effectively promotes hair growth with fewer side effects than oral treatments.